Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
TRAW on Nasdaq
There are no Buy or Sell transactions made by ORBIMED ADVISORS LLC since 12 Mar 2025
Holdings reported by ORBIMED ADVISORS LLC for Traws Pharma, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
602,000 |
$282,940 |
$0.4700 |
16 Sep 2024 |
Indirect |
|
|
| Pre-Funded Warrant (right to buy) |
96,348 |
|
|
29 Dec 2024 |
Indirect |
Common Stock |
|
| Series A Warrant (right to buy) |
96,348 |
|
|
29 Dec 2024 |
Indirect |
Common Stock |
|
Transactions reported by ORBIMED ADVISORS LLC for Traws Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.